Atherosclerosis is a major cause of mortality worldwide. The important role inflammation plays in atherosclerosis is evident through the participation of inflammatory cells in the development and progression of the disease. Thrombin is the central protease of the coagulation cascade, involved in the formation of a hemostatic plug to avoid severe bleeding. In addition, thrombin is a key factor in regulating inflammatory processes, signaling through protease activated receptors. We propose that thrombin may be a relevant factor in the atherosclerosis coagulation-inflammation axis. Human histological data show abundant coagulation activity within atherosclerotic lesions with thrombin activity being related to atherosclerotic plaque development and (in)stability. Animal studies establish that the generated thrombin level relates to progression of atherosclerosis, with hypercoagulability producing advanced atherosclerosis in mice with an Apolipoprotein E-deficient (ApoE(-/-)) background. Several studies show that administration of direct oral anticoagulants, like dabigatran and rivaroxaban, attenuate atherosclerosis development in ApoE(-/-) mice. In this review we explore several mechanisms by which thrombin may operate in modifying the chronic process of atherosclerosis. One of the key elements may be the conversion of thrombin, from a physiological regulator of hemostasis towards an inflammation-mediator under pathophysiological conditions, contributing to a switch in the thrombin-activated protein C (APC) regulation. The ongoing inflammatory activity, indicated by the activation of pro-inflammatory cytokines, neutrophils and neutrophil extracellular traps, drive thrombin generation, while diminishing APC formation. The net result is accelerated pro-inflammatory and pro-thrombotic changes in blood and in the vessel wall. We conclude that these atherogenic influences of thrombin may be clinically relevant in the long term. Further the treatment with long-term anticoagulant therapy deserves further attention as to its potential, vascular side effects.
机构:Maastricht University,Laboratory for Clinical Thrombosis and Haemostasis, Department of Internal Medicine, Cardiovascular Research Institute Maastricht
Jana Kalz
Hugo ten Cate
论文数: 0引用数: 0
h-index: 0
机构:Maastricht University,Laboratory for Clinical Thrombosis and Haemostasis, Department of Internal Medicine, Cardiovascular Research Institute Maastricht
Hugo ten Cate
Henri M. H. Spronk
论文数: 0引用数: 0
h-index: 0
机构:Maastricht University,Laboratory for Clinical Thrombosis and Haemostasis, Department of Internal Medicine, Cardiovascular Research Institute Maastricht
Henri M. H. Spronk
Journal of Thrombosis and Thrombolysis,
2014,
37
: 45
-
55
机构:
First Pavlov State Med Univ, St Petersburg, Russia
North West Fed Almazov Med Res Ctr, St Petersburg, RussiaFirst Pavlov State Med Univ, St Petersburg, Russia
Napalkova, Olga
Emanuel, Vladimir
论文数: 0引用数: 0
h-index: 0
机构:
First Pavlov State Med Univ, St Petersburg, RussiaFirst Pavlov State Med Univ, St Petersburg, Russia
Emanuel, Vladimir
Vavilova, Tatiana
论文数: 0引用数: 0
h-index: 0
机构:
North West Fed Almazov Med Res Ctr, St Petersburg, RussiaFirst Pavlov State Med Univ, St Petersburg, Russia
Vavilova, Tatiana
Karpenko, Mikhail
论文数: 0引用数: 0
h-index: 0
机构:
North West Fed Almazov Med Res Ctr, St Petersburg, RussiaFirst Pavlov State Med Univ, St Petersburg, Russia
Karpenko, Mikhail
Lapin, Sergey
论文数: 0引用数: 0
h-index: 0
机构:
First Pavlov State Med Univ, St Petersburg, RussiaFirst Pavlov State Med Univ, St Petersburg, Russia
Lapin, Sergey
Yudina, Victoria
论文数: 0引用数: 0
h-index: 0
机构:
First Pavlov State Med Univ, St Petersburg, RussiaFirst Pavlov State Med Univ, St Petersburg, Russia
机构:
Mashhad Univ Med Sci, Dept Med Biochem, Fac Med, Mashhad, IranMashhad Univ Med Sci, Dept Med Biochem, Fac Med, Mashhad, Iran
Jaberi, Najmeh
Soleimani, Atena
论文数: 0引用数: 0
h-index: 0
机构:
Mashhad Univ Med Sci, Dept Med Biochem, Fac Med, Mashhad, IranMashhad Univ Med Sci, Dept Med Biochem, Fac Med, Mashhad, Iran
Soleimani, Atena
Pashirzad, Mehran
论文数: 0引用数: 0
h-index: 0
机构:
Mashhad Univ Med Sci, Dept Med Biochem, Fac Med, Mashhad, IranMashhad Univ Med Sci, Dept Med Biochem, Fac Med, Mashhad, Iran
Pashirzad, Mehran
Abdeahad, Hosein
论文数: 0引用数: 0
h-index: 0
机构:
Mashhad Univ Med Sci, Dept Med Biochem, Fac Med, Mashhad, IranMashhad Univ Med Sci, Dept Med Biochem, Fac Med, Mashhad, Iran
Abdeahad, Hosein
Mohammadi, Fariba
论文数: 0引用数: 0
h-index: 0
机构:
Mashhad Univ Med Sci, Dept Med Biochem, Fac Med, Mashhad, IranMashhad Univ Med Sci, Dept Med Biochem, Fac Med, Mashhad, Iran
Mohammadi, Fariba
Khoshakhlagh, Mahdieh
论文数: 0引用数: 0
h-index: 0
机构:
Mashhad Univ Med Sci, Dept Med Biochem, Fac Med, Mashhad, IranMashhad Univ Med Sci, Dept Med Biochem, Fac Med, Mashhad, Iran
Khoshakhlagh, Mahdieh
论文数: 引用数:
h-index:
机构:
Khazaei, Majid
Ferns, Gordon A.
论文数: 0引用数: 0
h-index: 0
机构:
Brighton & Sussex Med Sch, Div Med Educ, Brighton, Sussex, EnglandMashhad Univ Med Sci, Dept Med Biochem, Fac Med, Mashhad, Iran
Ferns, Gordon A.
Avan, Amir
论文数: 0引用数: 0
h-index: 0
机构:
Mashhad Univ Med Sci, Metab Syndrome Res Ctr, Mashhad, Iran
Mashhad Univ Med Sci, Sch Med, Dept Modern Sci & Technol, Mashhad, IranMashhad Univ Med Sci, Dept Med Biochem, Fac Med, Mashhad, Iran
Avan, Amir
Hassanian, Seyed Mahdi
论文数: 0引用数: 0
h-index: 0
机构:
Mashhad Univ Med Sci, Dept Med Biochem, Fac Med, Mashhad, Iran
Mashhad Univ Med Sci, Metab Syndrome Res Ctr, Mashhad, IranMashhad Univ Med Sci, Dept Med Biochem, Fac Med, Mashhad, Iran